Oue Lippo Healthcare Posts Jump in H1 Revenue Even as EPS Declines
Oue Lippo Healthcare Posts Jump in H1 Revenue Even as EPS DeclinesOUE Lippo Healthcare发布上半年收入跃升，尽管每股收益下降
OUE Lippo Healthcare发布上半年收入跃升，尽管每股收益下降
08:22 AM EDT, 08/05/2022 (MT Newswires) -- Oue Lippo Healthcare (SGX:5WA), reported that revenue for the six months ending June 30, 2022 rose to SG$42.6 million ($30.96 million), up from SG$9.7 million in the same period last year.
The subsidiary of real estate development, investment and management company OUE Limited (SGX:LJ3) recorded earnings per share of SG$0.00127, from the prior period's SG$0.01724 per share.
Price (SGD): S$0.03, Change: S$0.00, Percent Change: +3.12%
风险提示：以上内容仅作为作者或者嘉宾的观点，不代表富途的任何立场，不构成与富途相关的任何投资建议。在作出任何投资决定前，投资者应根据自身情况考虑投资产品相关的风险因素，并于需要时咨询专业投资顾问意见。富途竭力但不能证实上述内容的真实性、准确性和原创性，对此富途不做任何保证和承诺。